The "Female Ovarian Reserve" test package is a specialised group of hormonal tests that assess a woman's reproductive potential. The quantity and quality of a woman's eggs decrease naturally with age, but certain health issues can also affect ovarian reserve. These tests are essential for evaluating fertility, especially in the context of family planning or assessing the need for fertility treatments.

Ovarian Reserve Tests

• FSH (Follicle-Stimulating Hormone): FSH is critical for stimulating the growth of eggs in the ovaries. Elevated levels of FSH early in the menstrual cycle can be a sign of a diminished ovarian reserve.

• LH (Luteinising Hormone): LH is involved in the ovulation process. Abnormal LH levels can indicate issues with the menstrual cycle or ovarian reserve.

• Oestradiol: A primary form of estrogen, oestradiol helps regulate the menstrual cycle and egg maturation. High levels of oestradiol can sometimes mask elevated FSH levels, which can be indicative of a reduced ovarian reserve.

• Prolactin: High levels of prolactin can interfere with ovulation, affecting a woman's fertility and potentially her ovarian reserve.

• AMH (Anti-Müllerian Hormone): AMH is produced by the cells of developing egg sacs (follicles). The level of AMH in a woman's blood is generally a good indicator of her ovarian reserve. Unlike other hormones, AMH does not fluctuate significantly throughout the menstrual cycle and can be measured on any day.

These tests collectively help in estimating the number of remaining eggs and predicting how well the ovaries are functioning. This is particularly useful for women considering delayed childbearing or those undergoing fertility treatments. Low levels of ovarian reserve indicate a lower likelihood of conceiving both naturally and with assisted reproductive technologies.